Pay in 4 interest-free payments of $7.12 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
392 :e085304 doi:10.1136/bmj-2025-085304 Prime Therapeutics
Preclinical and initial human studies suggest that glucagon-like peptide-1 receptor agonists may be promising treatments for alcohol use disorder, but existing approved treatments should be used until safety and efficacy is demonstrated in clinical trials
Any excess is typically excreted in the urine, lowering the risk of toxicity
However, depending on the pharmacy you use, your prescription drug coverage, and whether you have any pharmacy discounts or savings cards, your payment may be higher or lower than that
These usually improve over time
US$ 21.08
US$ 28.48
US$ 29.96
US$ 27.66
